publicações selecionadas
-
artigo académico
- Light Assisted Covalent Immobilization of Proteins for Biomedical Applications. Small. 2025
- Pleiotropic Leukemia Inhibitory Factor Encapsulated in DODAB:MO Liposomes for Multiple Biomedical Applications. Drug Delivery Letters. 2025
- Elastin-like Recombinamers as a Biotechnological Platform for the Development of Cytokine-Functionalized Materials. ACS Omega. 2024
- Leukemia inhibitory factor: Recent advances and implications in biotechnology. Cytokine & Growth Factor Reviews. 2020
-
artigo de conferência
-
documento
- (Nano)structured bioactive materials for the delivery of pleiotropic leukemia inhibitory factor 2025
- Development of bioplatforms for the controlled delivery of cytokine leukemia inhibitory factor 2024
- Nature-inspired platforms for pleiotropic cytokine delivery 2023
- Biotechnological production and delivery of pleiotropic cytokines for multiple biomedical purposes 2023
- Production and purification of pleiotropic recombinant cytokines for biomedical applications 2022
- Production and purification of pleiotropic recombinant cytokines for tissue engineering 2022
- Development of liposomal vectors for effective delivery of pleiotropic recombinant leukemia inhibitory factor (LIF) cytokine 2020
- DODAB:MO versus novel liposomes for protein delivery: comparing toxicity and encapsulation efficiency 2019
-
teses